|
1
|
DeLuca JG and Musacchio A: Structural
organization of the kinetochore-microtubule interface. Curr Opin
Cell Biol. 24:48–56. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cheeseman IM and Desai A: Molecular
architecture of the kinetochore-microtubule interface. Nat Rev Mol
Cell Biol. 9:33–46. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Wilson-Kubalek EM, Cheeseman IM, Yoshioka
C, Desai A and Milligan RA: Orientation and structure of the Ndc80
complex on the microtubule lattice. J Cell Biol. 182:1055–1061.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dominguez-Brauer C, Thu KL, Mason JM,
Blaser H, Bray MR and Mak TW: Targeting mitosis in cancer: Emerging
strategies. Mol Cell. 60:524–536. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ma L, McQueen J, Cuschieri L, Vogel J and
Measday V: Spc24 and Stu2 promote spindle integrity when DNA
replication is stalled. Mol Biol Cell. 18:2805–2816.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bharadwaj R and Yu H: The spindle
checkpoint, aneuploidy, and cancer. Oncogene. 23:2016–2027.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nelson WG, De Marzo AM and Isaacs WB:
Prostate cancer. N Engl J Med. 349:366–381. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gutiérrez-González E, Castelló A,
Fernández-Navarro P, Castaño-Vinyals G, Llorca J, Salas D,
Salcedo-Bellido I, Aragonés N, Fernández-Tardón G, Alguacil J, et
al: Dietary zinc and risk of prostate cancer in Spain: MCC-Spain
Study. Nutrients. 11(18)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hung SC, Lai SW, Tsai PY, Chen PC, Wu HC,
Lin WH and Sung FC: Synergistic interaction of benign prostatic
hyperplasia and prostatitis on prostate cancer risk. Br J Cancer.
108:1778–1783. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dai X, Fang X, Ma Y and Xianyu J: Benign
prostatic hyperplasia and the risk of prostate cancer and bladder
cancer: A meta-analysis of observational studies. Medicine
(Baltimore). 95(e3493)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Boorjian SA, Eastham JA, Graefen M,
Guillonneau B, Karnes RJ, Moul JW, Schaeffer EM, Stief C and Zorn
KC: A critical analysis of the long-term impact of radical
prostatectomy on cancer control and function outcomes. Eur Urol.
61:664–675. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sharma N and Baruah MM: The microRNA
signatures: Aberrantly expressed miRNAs in prostate cancer. Clin
Transl Oncol. 21:126–144. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou J, Pei Y, Chen G, Cao C, Liu J, Ding
C, Wang D, Sun L, Xu P and Niu G: SPC24 Regulates breast cancer
progression by PI3K/AKT signaling. Gene. 675:272–277.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou J, Yu Y, Pei Y, Cao C, Ding C, Wang
D, Sun L and Niu G: A potential prognostic biomarker SPC24 promotes
tumorigenesis and metastasis in lung cancer. Oncotarget.
8:65469–65480. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yin H, Meng T, Zhou L, Chen H and Song D:
SPC24 is critical for anaplastic thyroid cancer progression.
Oncotarget. 8:21884–21891. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sheng J, Yin M, Sun Z, Kang X, Liu D,
Jiang K, Xu J, Zhao F, Guo Q and Zheng W: SPC24 promotes
osteosarcoma progression by increasing EGFR/MAPK signaling.
Oncotarget. 8:105276–105283. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tokuzumi A, Fukushima S, Miyashita A,
Nakahara S, Kubo Y, Yamashita J, Harada M, Nakamura K, Kajihara I,
Jinnin M and Ihn H: Cell division cycle-associated protein 1 as a
new melanoma-associated antigen. J Dermatol. 43:1399–1405.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Obara W, Sato F, Takeda K, Kato R, Kato Y,
Kanehira M, Takata R, Mimata H, Sugai T, Nakamura Y and Fujioka T:
Phase I clinical trial of cell division associated 1 (CDCA1)
peptide vaccination for castration resistant prostate cancer.
Cancer Sci. 108:1452–1457. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
McCleland ML, Kallio MJ, Barrett-Wilt GA,
Kestner CA, Shabanowitz J, Hunt DF, Gorbsky GJ and Stukenberg PT:
The vertebrate Ndc80 complex contains Spc24 and Spc25 homologs,
which are required to establish and maintain
kinetochore-microtubule attachment. Curr Biol. 14:131–137.
2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cui F, Hu J, Fan Y, Tan J and Tang H:
Knockdown of spindle pole body component 25 homolog inhibits cell
proliferation and cycle progression in prostate cancer. Oncol Lett.
15:5712–5720. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hanahan D and Weinberg RA: The hallmarks
of cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wei RR, Sorger PK and Harrison SC:
Molecular organization of the Ndc80 complex, an essential
kinetochore component. Proc Natl Acad Sci USA. 102:5363–5367.
2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wei RR, Schnell JR, Larsen NA, Sorger PK,
Chou JJ and Harrison SC: Structure of a central component of the
yeast kinetochore: The Spc24p/Spc25p globular domain. Structure.
14:1003–1009. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sun SC, Lee SE and Xu YN: Perturbation of
SPC25 expression affects meiotic spindle organization, chromosome
alignment and spindle assembly checkpoint in mouse oocytes. Cell
cycle. 9:4552–4559. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang T, Zhou Y, Wang HH, Meng TG, Guo L,
Ma XS, Shen W, Schatten H and Sun QY: SPC24 is required for meiotic
kinetochore-microtubule attachment and production of euploid eggs.
Oncotarget. 7:71987–71997. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Charters GA, Stones CJ, Shelling AN,
Baguley BC and Finlay GJ: Centrosomal dysregulation in human
metastatic melanoma cell lines. Cancer Genet. 204:477–485.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tomonaga T, Matsushita K, Ishibashi M,
Nezu M, Shimada H, Ochiai T, Yoda K and Nomura F: Centromere
protein H is up-regulated in primary human colorectal cancer and
its overexpression induces aneuploidy. Cancer Res. 65:4683–4689.
2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang H, Gao X, Lu X, Wang Y, Ma C, Shi Z,
Zhu F, He B, Xu C and Sun Y: The mitotic regulator Hec1 is a
critical modulator of prostate cancer through the long non-coding
RNA BX647187 in vitro. Biosci Rep. 35(e00273)2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang LY, Chang CC, Lee YS, Chang JM,
Huang JJ, Chuang SH, Kao KJ, Lau GM, Tsai PY, Liu CW, et al:
Activity of a novel Hec1-targeted anticancer compound against
breast cancer cell lines in vitro and in vivo. Mol Cancer Ther.
13:1419–1430. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chmielewska AE, Tang NH and Toda T: The
hairpin region of Ndc80 is important for the kinetochore
recruitment of Mph1/MPS1 in fission yeast. Cell Cycle. 15:740–747.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tang NH and Toda T: MAPping the Ndc80 loop
in cancer: A possible link between Ndc80/Hec1 overproduction and
cancer formation. Bioessays. 37:248–256. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Musacchio A: The molecular biology of
spindle assembly checkpoint signaling dynamics. Curr Biol.
25:R1002–R1018. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lara-Gonzalez P, Westhorpe FG and Taylor
SS: The spindle assembly checkpoint. Curr Biol. 22:R966–R980.
2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ricke RM, Jeganathan KB and van Deursen
JM: Bub1 overexpression induces aneuploidy and tumor formation
through Aurora B kinase hyperactivation. J Cell Biol.
193:1049–1064. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Marks LS, Fradet Y, Deras IL, Blasé A,
Mathis J, Aubin SM, Cancio AT, Desaulniers M, Ellis WJ, Rittenhouse
H and Groskopf J: Pca3 molecular urine assay for prostate cancer in
men undergoing repeat biopsy. Urology. 69:532–535. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Merola R, Tomao L, Antenucci A, Sperduti
I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R,
Guaglianone S, et al: Pca3 in prostate cancer and tumor
aggressiveness detection on 407 high-risk patients: A national
cancer institute experience. J Exp Clin Cancer Res.
34(15)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mao Z, Ji A, Yang K, He W, Hu Y, Zhang Q,
Zhang D and Xie L: Diagnostic performance of PCA3 and hK2 in
combination with serum PSA for prostate cancer. Medicine
(Baltimore). 97(e12806)2018.PubMed/NCBI View Article : Google Scholar
|
